Increased risk of parkinson's disease in patients with end-stage renal disease: A retrospective cohort study

Neuroepidemiology

Volumn 42, Issue 4, 2014, Pages 204-210

  Wang, I Kuan ^a,b   Lin, Cheng Li ^b,c   Wu, Yi Ying ^c   Chou, Che Yi ^b   Lin, Shih Yi ^b   Liu, Jiung Hsiun ^b   Yen, Tzung Hai ^d,e   Huang, Chiu Ching ^b   Sung, Fung Chang ^b,c  

^a Management Office for Health Data   (China)

^b China Medical University Hospital   (China)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

End stage renal disease; Parkinson's disease; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEAD INJURY; HEALTH INSURANCE; HUMAN; HYPERTENSION; ICD-9-CM; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; TREATMENT DURATION; AGE DISTRIBUTION; COMORBIDITY; DISEASE PREDISPOSITION; HIGH RISK PATIENT; POPULATION RESEARCH; SEX DIFFERENCE; URBAN AREA; AGE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED;

AGE FACTORS; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 84898671911     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000358921     Document Type: Article

References (33)

1. de Lau LM, Breteler MM: Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-535.
2. Tolosa E, Wenning G, Poewe W: The diagnosis of Parkinson's disease. Lancet Neurol 2006; 5: 75-86.
3. Nussbaum RL, Ellis CE: Alzheimer's disease and Parkinson's disease. N Engl J Med 2003; 348: 1356-1364.
4. Brouns R, De Deyn PP: Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004; 107: 1-16.
5. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K: Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006; 10: 153-167.
6. Cupidi C, Piccoli F, La Bella V: Acute reversible parkinsonism in a diabetic-uremic patient. Clin Neurol Neurosurg 2006; 108: 601-603.
7. da Silva CJ, da Rocha AJ, Jeronymo S, Mendes MF, Milani FT, Maia AC Jr, Braga FT, Sens YA, Miorin LA: A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. AJNR Am J Neuroradiol 2007; 28: 1474-1479.
8. Kim TK, Seo SI, Kim JH, Lee NJ, Seol HY: Diffusion-weighted magnetic resonance imaging in the syndrome of acute bilateral basal ganglia lesions in diabetic uremia. Mov Disord 2006; 21: 1267-1270.
9. Lee EJ, Park JH, Ihn Y, Kim YJ, Lee SK, Park CS: Acute bilateral basal ganglia lesions in diabetic uraemia: diffusion-weighted MRI. Neuroradiology 2007; 49: 1009-1013.
10. Lee PH, Shin DH, Kim JW, Song YS, Kim HS: Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema. Parkinsonism Relat Disord 2006; 12: 93-96.
11. Lee YH: Diabetic nephropathy with acute symmetrical changes in the basal ganglia regions. Clin Radiol 2005; 60: 815-820.
12. Li JY, Yong TY, Sebben R, Khoo E, Disney AP: Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy. Nephrology (Carlton) 2008; 13: 68-72.
13. Ohtake T, Negishi K, Okamoto K, Oka M, Maesato K, Moriya H, Kobayashi S: Manganese-induced parkinsonism in a patient undergoing maintenance hemodialysis. Am J Kidney Dis 2005; 46: 749-753.
14. Okada J, Yoshikawa K, Matsuo H, Kanno K, Oouchi M: Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology 1991; 33: 524-526.
15. Wang HC, Brown P, Lees AJ: Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord 1998; 13: 952-957.
16. Wang HC, Cheng SJ: The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients. J Neurol 2003; 250: 948-955.
17. Lin HL, Lin HC, Chen YH: Increased risks of parkinsonism in the 3 years after chronic renal failure. Int J Clin Pract 2012; 66: 499-503.
18. Greenamyre JT, Hastings TG: Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science 2004; 304: 1120-1122.
19. Arieff AI: Aluminum and the pathogenesis of dialysis encephalopathy. Am J Kidney Dis 1985; 6: 317-321.
20. Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y: A hemodialysis patient with trazodone-induced parkinsonism. Nephron 2002; 90: 222-223.
21. Sethi KD, Patel B, Meador KJ: Metoclopramide-induced parkinsonism. South Med J 1989; 82: 1581-1582.
22. Sirota RA, Kimmel PL, Trichtinger MD, Diamond BF, Stein HD, Yudis M: Metoclopramide-induced parkinsonism in hemodialysis patients: report of two cases. Arch Intern Med 1986; 146: 2070-2071.
23. Kimmel PL, Phillips TM, Phillips E, Bosch JP: Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 1990; 38: 129-135.
24. Raj DS, Boivin MA, Dominic EA, Boyd A, Roy PK, Rihani T, Tzamaloukas AH, Shah VO, Moseley P: Haemodialysis induces mitochondrial dysfunction and apoptosis. Eur J Clin Invest 2007; 37: 971-977.
25. Raj DS, Dominic EA, Pai A, Osman F, Morgan M, Pickett G, Shah VO, Ferrando A, Moseley P: Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int 2005; 68: 2338-2344.
26. Cereda E, Barichella M, Pedrolli C, Klersy C, Cassani E, Caccialanza R, Pezzoli G: Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 2011; 34: 2614-2623.
27. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J: Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007; 30: 842-847.
28. Sun Y, Chang YH, Chen HF, Su YH, Su HF, Li CY: Risk of Parkinson disease onset in patients with diabetes: a 9-year populationbased cohort study with age and sex stratifications. Diabetes Care 2012; 35: 1047-1049.
29. Sandyk R, Kay SR, Awerbuch GI, Iacono RP: Risk factors for neuroleptic-induced movement disorders. Int J Neurosci 1991; 61: 149-188.
30. Hsu JL, Wang HC, Hsu WC: Hyperglycemiainduced unilateral basal ganglion lesions with and without hemichorea: a PET study. J Neurol 2004; 251: 1486-1490.
31. Lai SL, Tseng YL, Hsu MC, Chen SS: Magnetic resonance imaging and single-photon emission computed tomography changes in hypoglycemia-induced chorea. Mov Disord 2004; 19: 475-478.
32. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML: Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-242.
33. Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY: Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 2005; 104: 157-163.